These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 33443871)

  • 1. Effect of Different Antithrombotic Regimens to Prevent Postoperative Restenosis in Patients With Lower Extremity Arteriosclerosis.
    Gao Z; Qin Y; Yu T; Wang W; Zhu CY; Qiao T; Li XQ; Da L; Ran F
    Am J Ther; 2021 Feb; 28(4):e517-e520. PubMed ID: 33443871
    [No Abstract]   [Full Text] [Related]  

  • 2. Local delivery of antithrombotic drug prevents restenosis after balloon angioplasty in atherosclerotic rabbit artery.
    Tomaru T; Fujimori Y; Morita T; Aoki N; Sakamoto Y; Nakamura F; Omata M; Uchida Y
    Jpn Circ J; 1996 Dec; 60(12):981-92. PubMed ID: 8996689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Batroxobin plus aspirin reduces restenosis after angioplasty for arterial occlusive disease in diabetic patients with lower-limb ischemia.
    Wang J; Zhu YQ; Li MH; Zhao JG; Tan HQ; Wang JB; Liu F; Cheng YS
    J Vasc Interv Radiol; 2011 Jul; 22(7):987-94. PubMed ID: 21570870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasma heparin cofactor II activity correlates with the incidence of in-stent restenosis after the intervention of arteriosclerosis obliterans in lower extremity].
    Lu H; Guo P
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Feb; 40(2):177-81. PubMed ID: 25769326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preoperative care of microcirculatory vessels in patients with lower limb arteriosclerosis obliterans].
    Kuznetsov MR; Koshkin VM; Karalkin AV; Boldin BV; Rodionov SV; Sergeeva NA; Petukhov EB; Golosnitskiĭ PIu
    Angiol Sosud Khir; 2005; 11(1):19-24. PubMed ID: 16034319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is angiotensin receptor blockade antithrombotic?
    Lim HS; Lip GY
    Arch Intern Med; 2003 Dec 8-22; 163(22):2790-1; author reply 2792-3. PubMed ID: 14662638
    [No Abstract]   [Full Text] [Related]  

  • 7. [Arteriosclerosis and atherogenic drugs].
    Navarrete Pando G
    Angiologia; 1976; 28(1):12-20. PubMed ID: 1008301
    [No Abstract]   [Full Text] [Related]  

  • 8. Antithrombotic therapy in peripheral arterial occlusive disease.
    Jackson MR; Clagett GP
    Chest; 2001 Jan; 119(1 Suppl):283S-299S. PubMed ID: 11157655
    [No Abstract]   [Full Text] [Related]  

  • 9. [The efficacy of antithrombotic therapy after total obliteration-reversing therapy in atherosclerotic arterial occlusion of the lower extremities].
    Luk'ianov IuV; Sedov VM; Lebedev LV; Shlomin VV; Kas'ianov IV; Batalin IV; Kondrat'ev VM
    Vestn Khir Im I I Grek; 1997; 156(1):62-5. PubMed ID: 9163197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic therapy for postinterventional management of peripheral arterial disease.
    Zavgorodnyaya D; Knight TB; Daley MJ; Teixeira PG
    Am J Health Syst Pharm; 2020 Feb; 77(4):269-276. PubMed ID: 31930282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fibrinolytic factors in atherosclerosis].
    Coccheri S
    Bull Sci Med (Bologna); 1967; 139(4):474-80. PubMed ID: 4236949
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current problems of antithrombotic therapy].
    Liusov VA; Belousov IuB
    Kardiologiia; 1981 Aug; 21(8):5-17. PubMed ID: 7026869
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ultrasound-guided peripheral nerve block for high-risk patients with arteriosclerosis obliterans in lower limb surgery--a report of nine cases].
    Kido K; Ito H; Makita K
    Masui; 2012 Oct; 61(10):1117-20. PubMed ID: 23157100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue factor pathway inhibitors as a novel approach to antithrombotic therapy.
    Sajadi S; Ezekowitz MD; Dhond A; Netrebko P
    Drug News Perspect; 2003; 16(6):363-9. PubMed ID: 12973447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits of antithrombotic therapy after infrainguinal bypass grafting: a meta-analysis.
    Collins TC; Souchek J; Beyth RJ
    Am J Med; 2004 Jul; 117(2):93-9. PubMed ID: 15234644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of long-term therapy with phenformin plus metanabol on blood fibrinolytic activity, platelet adhesiveness and lipid metabolism in patients with arteriosclerosis.
    Perzanowski A; Bielawiec M; Myśliwiec M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(3):381-8. PubMed ID: 63425
    [No Abstract]   [Full Text] [Related]  

  • 17. Fibrinolytic effects of defibrotide in atherosclerotic patients.
    Patrassi GM; Sartori MT; Viero ML; Scapinello MP; Boeri G; Girolami A
    Semin Thromb Hemost; 1991; 17 Suppl 1():101-5. PubMed ID: 2068562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preangioplasty fibrinolytic therapy using SP-54 including acute and subacute occlusions.
    Haapanen A; Leinonen A; Seppänen S
    Ann Radiol (Paris); 1984; 27(4):340. PubMed ID: 6204575
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term antithrombotic therapy after venous stent placement.
    Lin C; Martin KA; Wang M; Stein BL; Desai KR
    Phlebology; 2020 Jul; 35(6):402-408. PubMed ID: 31821779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proceedings of the International Symposium "Update in Thrombolysis 2000: Arteriosclerosis, Thrombosis and Cardiovascular Biology". October 12-14, 2000, Vienna, Austria.
    Thromb Res; 2001 Sep; 103 Suppl 1():S1-149. PubMed ID: 11840980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.